Fatih Selcukbiricik
5PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu
|Apr 02, 2025
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case report.Bahadır Köylü, Cevat İlteriş Kıkılı, Öner Dikensoy
|Jul 01, 2024
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.Arif Akyildiz, Melis Gultekin, Ecem Yigit
|Aug 09, 2021
Palliative care needs of the cancer patients receiving active therapy.Gülcan Bağçivan, Memnun Seven, Şeyma İnciser Paşalak
|Nov 29, 2019
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.Fatih Selcukbiricik, Elif Ozdogan, Tuncay Dagel
Pageof 1
Frequent Collaborators
2 joint publications
Bahadır Köylü
1 joint publications
Gülcan Bağçivan
1 joint publications
Memnun Seven
1 joint publications
Şeyma İnciser Paşalak
1 joint publications
Ezgi Bilmiç
1 joint publications
Arif Akyildiz
1 joint publications
Melis Gultekin
1 joint publications
Ecem Yigit
1 joint publications
Ecem Demir
1 joint publications
Rashad Ismayilov
